Vendor Watch
Allscripts CEO honored.
CHICAGO, IL – May 26, 2009 –
The Juvenile Diabetes Research Foundation Illinois (JDRF Illinois), the state chapter of the leading charitable funder and advocate of type 1 diabetes research worldwide, has named
Glen Tullman, Chief Executive Officer of
Allscripts (Nasdaq: MDRX), its "Best of Illinois" for his service on both the Illinois Board of Directors and the organization's International Board.
Tullman and his wife have been active in their support of JDRF's efforts in developing an artificial pancreas. The honor was presented at the organization's annual Best of Illinois dinner May 21. The event raised more than $1 million, including over $500,000 for the Artificial Pancreas Program.
The development of an artificial pancreas, one of JDRF's top research priorities, would enable a person with diabetes to maintain normal glucose levels by continuously monitoring blood glucose levels and then providing an exact dose of insulin automatically through an integrated pump.
Tullman, whose son and niece have type-1 diabetes, told the audience, "I am honored to be recognized by JDRF Illinois, however the real reward will come only when we win the race to find a cure for diabetes once and for all."
"I am very optimistic that, through JDRF's cutting-edge research, which includes the Artificial Pancreas and other important breakthroughs, and the generosity of tens of thousands of supporters around the world, we will find a cure for this terrible disease, which millions of us confront in our own families every day."
Tullman is a longtime active supporter and advocate for JDRF and has contributed to raising millions of dollars in search of a cure, including his family's own contributions, which are measured in the millions by themselves. He has also encouraged his company to become a lead sponsor of JDRF volunteer fundraising events in Illinois, North Carolina, Vermont and other states where Allscripts has offices.
"Glen Tullman is a passionate and selfless advocate of the JDRF cause who has worked to advance the cause for many years, both through his volunteer activities and his many generous gifts to the Foundation," said Patrick Reedy, Executive Director of JDRF Illinois. "Glen not only is a visionary leader in his own business of transforming our healthcare system using technology, but one of the many extraordinary Illinois leaders who share a common interest in supporting cutting edge research and technology that will lead to a cure for type 1 diabetes."
About JDRF
The Juvenile Diabetes Research Foundation International was founded in 1970 by the parents of children with type 1 diabetes and is now the world's largest charitable funder and advocate of type 1 diabetes research. The mission of JDRF is to find a cure for diabetes and its complications through the support of research. JDRF provided more than $137 million to diabetes research in FY 2007, and is responsible for more than $1.16 billion in direct funding since it was founded. JDRF annually receives top rankings from independent sources that rate charitable giving.
www.jdrf.org.
WOCN-Connect partners with wound care product vendor.
May 27, 2009 –
Homeline, Inc., a disposable medical products and negative pressure wound therapy distributor, has partnered with
Miller & Huffman Outcome Architects (MHOA), founders and developers of
WOCN-Connect and
BluePrint Series for Chronic Conditions. Together, the partners will offer comprehensive wound care solutions to healthcare providers via the web.
The collaboration aims to help home healthcare providers cut the costs of managing wounds while improving outcomes by supplying wound care products at low cost and by providing wound care expertise via remote guidance of a certified Wound, Ostomy and Continence Nurse.
“As healthcare costs continue to rise in nearly every segment, Homeline is committed to providing the highest quality products, education and training to the home healthcare market to keep costs contained,” says Homeline CEO Shirish Mody.
Homeline’s Life Care Delivered, which provides negative pressure wound therapy and wound supplies exclusively to home health agencies, hospices and wound centers, was launched at the 22nd Annual Symposium on Advanced Wound Care and Wound Healing Society in Dallas on April 26, 2009. The service combines the cutting-edge technology of the Venturi™ pump with a streamlined delivery service.
WOCN-Connect simplifies the complexity of wound care by guiding staff to select the right product from their own product formulary for the right wound at the right time to improve healing times. WOCN-Connect software also captures and aggregates outcomes by wound type for subscribers’ internal and external benchmarking.
About the partners
Homeline, Inc. is a supplier of home healthcare products to home care providers, hospices, wound clinics and consumers through two subsidiaries, "Life Care Delivered" and "Medical Supply Boutique." The parent company has sales offices in San Diego, San Francisco, Dallas, Atlanta and Louisville.
www.homeline4u.com
WOCN-Connect is a web-based tele-woundcare service of Tennessee-based Miller & Huffman Outcomes Architects (MHOA). Principals Colleen Miller, RN,BS, CSBC, and Melinda Huffman, BSN, MSN, CCNS, are experts in home health outcomes and disease management. MHOA designs, develops and delivers outcome-based systems to improve clinical and financial outcomes. WOCN-Connect is not affiliated with the Wound, Ostomy and Continence Nurses Society.
http://www.wocn-connect.com.
Another "Medical Clinical Assistant" Tablet PC appears, offering discount pricing.
May 28 , 2009 –
Tangent Inc.,
www.tangent.com, a provider of healthcare technology and based in Burlingame, California, announced today the release of
Medix 10T, a 10.4" Tablet PC built on Intel's "Medical Clinical Assistant" (MCA) design. We have previously carried announcements of Tablets built on the same design from
Motion Computing and
Panasonic.
Tangent says it will compete with earlier entries into this space on the basis of price.
The unit will also feature dual, hot-swappable batteries instead of a single battery; a touch-screen that responds to finger and stylus instead of stylus only; the "Digital Persona" biometric fingerprint reader and the more powerful Intel® ULV core duo processor, running at 1.06 GHz.
Tangent President Doug Monsour explains that the unit's 3.3 lb. weight and mobility make a convenient portable access point for healthcare database applications. "It is ideal as a Medical Clerical assistant, on nursing carts, for EMR and for all point-of-care applications," Monsour noted.
The
Medix 10T also offers a docking cradle for charging up to two batteries. Its rugged construction provides protection from accidental drops and most other work-place damage. It meets IP-54 standards for a dust-free, waterproof operation and can be sprayed and wiped down without risk of damage. Batteries recharge in less less than three hours. Security options include HDD User Password Protection and BIOS I/O lock.
The optional docking station incorporates a locking feature that provides a safe and secure stand when the unit is not in portable use. One LAN port and four USB 2.0 ports allow connectivity while the unit is in dock.
The Medix 10T uses the Intel® ULV processor U2100 1.06 GHz (533MHz FSB) and the Intel® 945GME chipset. It has up to 2GB DDR2 SDRAM and one SO-DIMM socket.
Base MSRP is $2,295.
www.medicalcomputer.tangent.com/medix10t_allinone.htm
